Many drugs come in two forms: expensive branded drugs and cheaper generic copies. Switzerland’s Federal Council hopes a shift to cheaper generic and bio-similar medicines can shave CHF 250 million from Switzerland’s rapidly rising cost of healthcare, reported SRF. New rules on medicine choices and health insurance were already set to come into force on 1 January 2024. However, this week the Federal Council announced that it will make the new rules tougher that first planned in the hope of...
Read More »Drugs in Switzerland more expensive than ever compared to Europe
A recent study by Interpharma and Santésuisse shows how rapidly drug prices have risen in Switzerland over the 10 years to 2020. © Artemiy Sobov | Dreamstime.comBetween 2010 and 2020, medicine prices have risen by nearly 37% in Switzerland. In addition, the cost of basic health insurance has risen at 3 times the rate of GDP over the same period. There are three main reasons for high Swiss drug prices according to the report: too many generic drugs, excessive margins and high factory...
Read More »Drug spending continues to explode in Switzerland
Last week, the government announced that it had shaved CHF 100 million off the cost of drug purchases from 1 January 2020. © Vitaly Iskakov | Dreamstime.com This week numbers obtained by RTS from Curafutura, a health insurance association, show drug spending rose CHF 420 million from CHF 6.9 billion to CHF 7 billion between October 2018 and September 2019 and the same period 12 month a year before. Over the last five years spending on drugs has risen 26%. Savings are not keeping up...
Read More »